Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southern Cross Capital is a venture capital and private equity firm that focuses on early-stage and growth-stage investments within the life sciences, healthcare, and technology sectors. The firm provides strategic capital and operational support to companies developing innovative medical devices, digital health solutions, and biotechnology platforms. By leveraging a deep network of industry experts and clinical partners, Southern Cross Capital aims to accelerate the commercialization of transformative healthcare technologies. Their portfolio typically includes companies that address significant unmet medical needs through disruptive innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Southern Cross Capital.